8 Neglected Tropical Diseases Receiving Increased Global Attention

7. Dengue and Vector Control - Urban Epidemic Meets Innovation

Dengue fever, while not traditionally classified among the most neglected tropical diseases, has gained unprecedented attention as urbanization and climate change have expanded its reach to affect over 390 million people annually across more than 100 countries. Transmitted by Aedes aegypti mosquitoes, dengue represents the fastest-spreading vector-borne disease globally, with incidence increasing eightfold over the past two decades. The increased focus on dengue has catalyzed innovative vector control strategies that extend beyond traditional approaches, including the release of genetically modified mosquitoes and Wolbachia-infected mosquitoes that reduce viral transmission. The World Mosquito Program has conducted groundbreaking field trials demonstrating that Wolbachia-infected mosquitoes can reduce dengue transmission by up to 77% in randomized controlled trials. Community-based vector control programs have proven highly effective, with countries like Singapore and Vietnam achieving significant reductions in mosquito breeding sites through sustained community engagement and education. The development of the first dengue vaccine, Dengvaxia, while facing initial challenges, has provided valuable lessons for future vaccine development and highlighted the importance of understanding local epidemiology before implementation. Recent innovations include the use of artificial intelligence and satellite imagery to predict dengue outbreaks, enabling proactive rather than reactive public health responses. The integration of dengue control with other vector-borne disease programs, particularly those targeting Zika and chikungunya, has created synergies that maximize the impact of limited resources while addressing multiple health threats simultaneously.

8. Human African Trypanosomiasis - Sleeping Sickness Awakens Hope

Human African trypanosomiasis, commonly known as sleeping sickness, has experienced one of the most dramatic transformations among neglected tropical diseases, declining from over 300,000 estimated cases in the 1990s to fewer than 1,000 reported cases in 2019. This vector-borne disease, transmitted by tsetse flies and caused by Trypanosoma brucei parasites, has historically devastated rural communities across sub-Saharan Africa, causing neurological damage and death if left untreated. The remarkable progress has been achieved through sustained political commitment, improved surveillance systems, and innovative public-private partnerships that have brought new diagnostic tools and treatments to remote endemic areas. The development of rapid diagnostic tests has revolutionized case detection, enabling healthcare workers in remote areas to diagnose the disease quickly and accurately without sophisticated laboratory infrastructure. Treatment has been transformed by the introduction of fexinidazole, an oral medication that can treat both stages of the disease caused by T. b. gambiense, replacing complex and dangerous treatment regimens that required hospitalization and intravenous administration. The WHO has set an ambitious target of eliminating sleeping sickness as a public health problem by 2030, and current trends suggest this goal is achievable. Vector control strategies have evolved to include innovative approaches such as tiny targets (insecticide-treated screens and traps) that specifically target tsetse flies while minimizing environmental impact. The success in controlling sleeping sickness has provided valuable lessons for addressing other vector-borne diseases and demonstrates that even the most challenging neglected tropical diseases can be brought under control with sustained effort and innovation.